期刊文献+

转录因子Foxp3在肺癌细胞的表达及其意义 被引量:4

The expression of Foxp3 in lung cancer cell and its significance
下载PDF
导出
摘要 目的研究转录因子Foxp3在肺癌细胞中的表达及其对肿瘤免疫的影响。方法用常规RT-PCR检测Foxp3在肺癌细胞系中的表达,进一步用Western blot验证其蛋白水平的表达;将表达Foxp3的肿瘤细胞及用Foxp3 siRNA沉默后的肿瘤细胞分别与CD4+CD25-T细胞共培养,CFSE评价免疫效应细胞增殖情况。结果 Foxp3在肺癌细胞系中出现表达;肺癌细胞与CD4+T细胞进行共培养,可显著抑制共培养体系中CD4+T细胞增殖;肺癌细胞Foxp3表达沉默后,可显著改善共培养体系中肺癌细胞对CD4+T细胞增殖的抑制作用。结论在肺细胞癌细胞系发现Foxp3的表达,肺癌细胞Foxp3的表达参与对肿瘤特异性T细胞增殖的抑制。 We aim to investigate the expression of fork head transcription Foxp3 in lung cancer cell lines and its significance in tumor immune micro-environment.Conventional RT-PCR technique was used to detect the expression of Foxp3 in lung cancer cell lines;Western blot was used to assess the expression level of protein.The tumor cells expressing Foxp3 and the tumor cells of Foxp3 siRNA-silence were cultured respectively with CD4+CD25-T cells,and the proliferation of the immune effector cells was evaluated by CFSE.We found that Foxp3 could be expressed in lung cancer lines;The proliferation of CD4+ T cells was notably inhibited in co-cultured system of lung cancer cells and CD4+ T cells.The inhibiting role of the lung cancer cell to the CD4+ T cell proliferation could notably be improved by silencing Foxp3.In conclusion,Foxp3 could expressed in lung cancer cell lines,and the expression of the lung cancer Foxp3 might be involved in inhibiting the proliferation of the tumor specific T cells.
出处 《免疫学杂志》 CAS CSCD 北大核心 2012年第2期112-115,共4页 Immunological Journal
基金 河南省卫生厅医学科技攻关计划(2010003083和200903099) 河南省科技厅科技发展计划基础与前沿项目(092300410112) 河南大学省部共建科研项目(SBGJ090715)
关键词 肺癌 FOXP3 肿瘤免疫 Lung cancer Foxp3 Tumor immune
  • 相关文献

参考文献16

  • 1Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3 [J]. Science, 2003, 299(5069) : 1057-1061. 被引量:1
  • 2Yano H, Ishida T, Inagaki A. et al. Regulatory T-cell function of adult T-cell leukemia/lymphoma cells[J]. Int J Cancer, 2007, 120(9):2052-2057. 被引量:1
  • 3Hinz S, Pagemls Raluy L, Oberg HH, el al. Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer [J]. Cancer Res, 2007, 67 (17) : 8344-8350. 被引量:1
  • 4白慧玲,裴景堂,杜耀武,李淑莲,刘广超,马远方.兔抗人DR5分子多克隆抗体的制备与初步应用[J].免疫学杂志,2008,24(6):634-637. 被引量:10
  • 5张尤翔.生物化学实验斤法和技术[M].北京:高等教育出版社,1985:94-112. 被引量:1
  • 6Kaplan DH, Shankaran V, Dighe AS, et al. Demonstrati,m of an interferon gamma-dependenl tumor surveillance syslem in immunocompetent mice [J]. Pine Natl Acad Sci USA, 1998, 95(13):7556-7561. 被引量:1
  • 7Shankaran V, lkeda H, Bruce. AT, et al. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity[J].Nature, 2001, 410(6832): 1107-1111. 被引量:1
  • 8田易,吴玉章,倪兵.FOXP3表达调控的研究进展[J].免疫学杂志,2010,26(9):823-826. 被引量:11
  • 9Petersen RP, Campa M J, Sperlazza J, et al. Tumor infiltrating Foxp3^+ regulatory T^- cells are associated with recurrence in pathologic stage I NSCI+C patients [J]. Cancer, 2006. 107(12) : 2866 -2872. 被引量:1
  • 10Miller AM, Lundberg K, Ozenci V, et al. CD4^+CD25high T ceils are enriched in the tumor and peripheral blood of prostate cancer palients [J]. J Immunol, 2006, 177(10): 7398- 7405. 被引量:1

二级参考文献48

共引文献29

同被引文献31

  • 1刘安丽,王成斌.老年口腔黏膜病变916例临床病理分析[J].临床军医杂志,2004,32(4):71-72. 被引量:1
  • 2Burzyn D,Benoist C,Mathis D.Regulatory T cells in nonlymphoid tissues[J].Nat Immunol,2013,14(10):1007-1013. 被引量:1
  • 3Martin F,Ladoire S,Mignot G,et al.Human FOXP3 and cancer[J].Oncogene,2010,29(29):4121-4129. 被引量:1
  • 4Tai X,Erman B,Alag A,et al.Foxp3 transcription factor is proapoptotic and lethal to developing regulatory T cells unless counterbalanced by cytokine survival signals[J].Immunity,2013,38 (6):1116-1128. 被引量:1
  • 5Ebert LM,Tan BS,Browning J,et al.The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells[J].Cancer Res,2008,68(8):3001-3009. 被引量:1
  • 6Hori S,Nomura T,Sakaguchi S.Control of regulatory T cell development by the transcription factor Foxp3. Science . 2003 被引量:4
  • 7Ana Izcue,Sophie Hue,Sofia Buonocore,Carolina V. Arancibia-Cárcamo,Philip P. Ahern,Yoichiro Iwakura,Kevin J. Maloy,Fiona Powrie.Interleukin-23 Restrains Regulatory T Cell Activity to Drive T Cell-Dependent Colitis[J]. Immunity . 2008 (4) 被引量:3
  • 8Alberto Mantovani,Pedro Romero,A Karolina Palucka,Francesco M Marincola.Tumour immunity: effector response to tumour and role of the microenvironment[J]. The Lancet . 2008 (9614) 被引量:1
  • 9Nicolas Larmonier,Marilyn Marron,Yi Zeng,Jessica Cantrell,Angela Romanoski,Marjan Sepassi,Sylvia Thompson,Xinchun Chen,Samita Andreansky,Emmanuel Katsanis.Tumor-derived CD4+CD25+ regulatory T cell suppression of dendritic cell function involves TGF-β and IL-10[J]. Cancer Immunology, Immunotherapy . 2007 (1) 被引量:1
  • 10Lohr Jens,Knoechel Birgit,Wang Jing Jing,Villarino Alejandro V,Abbas Abul K.Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. The Journal of experimental medicine . 2006 被引量:1

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部